FUNI Hypha Labs, Inc.
Services-Testing Laboratories · OTC · SEC CIK 1502966 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY36.7%
TTM EPS YoY66.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets4,618.5%
Debt / equity—
Current ratio0.01x
Interest coverage-4.40x
Cash quality & payout
Operating cash flow / net income0.30x
Accruals ratio-512.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-09-30 | FY20232023-09-30 | FY20222022-09-30 | FY20212021-09-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | $2.70M | $2.50M |
| Cost of revenue | — | — | — | $1.63M | $1.79M |
| Gross profit | — | — | — | $1.07M | $715,165 |
| SG&A expense | $1.42M | $943,691 | $103,298 | $495,762 | $934,143 |
| Operating income | -$3.00M | -$1.83M | -$437,388 | -$1.15M | -$772,448 |
| Interest expense | $106,143 | $201,769 | $364,267 | $244,586 | $144,957 |
| Pretax income | -$3.10M | -$1.36M | -$681,655 | — | — |
| Income tax | — | $14,189 | — | — | — |
| Net income | -$3.10M | -$785,429 | $246,774 | -$2.06M | -$686,503 |
| EBITDA | -$2.99M | -$1.83M | — | -$946,314 | -$480,315 |
| EPS (basic) | -0.02 | -0.01 | 0.00 | -0.03 | -0.01 |
| EPS (diluted) | -0.02 | -0.01 | 0.00 | -0.03 | -0.01 |
| Weighted avg. shares (diluted) | 135.15M | 101.35M | 83.93M | 74.17M | 65.87M |
| Banking | |||||
| Net interest income | — | — | — | $63,087 | $930 |
| Balance sheet | |||||
| Cash & equivalents | $38,118 | $91,166 | $271,006 | $56,168 | $295,932 |
| Receivables | — | — | — | $335,085 | $214,900 |
| Current assets | $320,531 | $410,190 | $765,798 | $562,104 | $826,865 |
| PP&E, net | $62,507 | $26,609 | — | $55,000 | $647,252 |
| Total assets | $409,218 | $493,805 | $1.41M | $1.34M | $1.89M |
| Current liabilities | $1.12M | $1.39M | $3.12M | $2.95M | $2.01M |
| Total liabilities | $2.51M | $1.42M | $3.28M | $3.75M | $2.94M |
| Shareholders' equity | -$2.44M | -$1.26M | -$2.21M | -$2.74M | -$1.05M |
| Shares outstanding | 147.12M | 123.05M | 87.10M | 75.15M | 71.23M |
| Cash flow statement | |||||
| Operating cash flow | -$379,975 | -$1.03M | $112,525 | -$184,786 | -$135,968 |
| Capital expenditure | $32,966 | $27,655 | — | $17,722 | $56,206 |
| Free cash flow | -$412,941 | -$1.06M | — | -$202,508 | -$192,174 |
| Investing cash flow | -$32,966 | $2.15M | $263,333 | -$660,371 | -$286,206 |
| Financing cash flow | $359,893 | -$1.29M | -$161,020 | $605,393 | $635,357 |
| Depreciation & amortization | $10,818 | $1,046 | — | $204,151 | $292,133 |
| Stock-based compensation | $1.85M | $733,748 | $59,154 | $566,233 | $403,886 |
Free plan shows the latest 5 periods; Pro shows all 15 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.